ATE345352T1 - Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse - Google Patents

Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse

Info

Publication number
ATE345352T1
ATE345352T1 AT01116856T AT01116856T ATE345352T1 AT E345352 T1 ATE345352 T1 AT E345352T1 AT 01116856 T AT01116856 T AT 01116856T AT 01116856 T AT01116856 T AT 01116856T AT E345352 T1 ATE345352 T1 AT E345352T1
Authority
AT
Austria
Prior art keywords
protein
parvovirus
composition
arvovirus
variant
Prior art date
Application number
AT01116856T
Other languages
English (en)
Inventor
Laurent Daeffler
Juerg Nueesch
Jean Rommelaere
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE345352T1 publication Critical patent/ATE345352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01116856T 2001-07-10 2001-07-10 Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse ATE345352T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01116856A EP1275658B1 (de) 2001-07-10 2001-07-10 Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse

Publications (1)

Publication Number Publication Date
ATE345352T1 true ATE345352T1 (de) 2006-12-15

Family

ID=8178011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01116856T ATE345352T1 (de) 2001-07-10 2001-07-10 Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse

Country Status (6)

Country Link
US (2) US20040208886A1 (de)
EP (1) EP1275658B1 (de)
AT (1) ATE345352T1 (de)
AU (1) AU2002336926A1 (de)
DE (1) DE60124523T2 (de)
WO (1) WO2003006067A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE345352T1 (de) * 2001-07-10 2006-12-15 Deutsches Krebsforsch Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse
EP1473306A1 (de) 2003-04-30 2004-11-03 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Als cytotoxin geeignetes fusionspolypeptid
EP2149583B1 (de) * 2004-09-24 2015-10-28 Novartis AG Modifiziertes VP1-Capsid Protein von Parvovirus B19
EP2404609A1 (de) 2010-07-07 2012-01-11 Deutsches Krebsforschungszentrum Verwendung vom Parvovirus zur Beseitigung von Krebsstammzellen
WO2014040040A1 (en) * 2012-09-10 2014-03-13 Merial Limited Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus ( derzsy's disease)
EP3738972A1 (de) 2019-05-13 2020-11-18 Deutsches Krebsforschungszentrum Parvolysin
WO2024196965A1 (en) * 2023-03-23 2024-09-26 Carbon Biosciences, Inc. Parvovirus compositions and related methods for gene therapy
US12383615B2 (en) 2023-03-23 2025-08-12 Carbon Biosciences, Inc. Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282998T3 (es) 1996-01-02 2007-10-16 Institut Pasteur Pseudo-particularmente viricas recombinadas y aplicaciomnes vacunales y antitumorales.
SE520177C2 (sv) * 1998-11-24 2003-06-03 Kristina Broliden Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
ATE345352T1 (de) 2001-07-10 2006-12-15 Deutsches Krebsforsch Zusammensetzung einer parvovirus vp1- proteinvariante und eines arvovirus ns1-proteins zur induktion von zytolyse

Also Published As

Publication number Publication date
AU2002336926A1 (en) 2003-01-29
DE60124523D1 (de) 2006-12-28
WO2003006067A3 (en) 2003-05-08
EP1275658B1 (de) 2006-11-15
US20040208886A1 (en) 2004-10-21
US20100029751A1 (en) 2010-02-04
EP1275658A1 (de) 2003-01-15
WO2003006067A2 (en) 2003-01-23
DE60124523T2 (de) 2007-09-06
US8450289B2 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
DE60035778D1 (de) Rekombinante influenzaviren zur vakzinherstellung und gentherapie
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
BRPI0512286A (pt) proteìnas quiméricas inibidoras da angiogênese e o uso
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
ATE394484T1 (de) Smad 6 und dessen anwendungen
EP1331271A4 (de) Die polypeptidfragmente des hepatitis-e-virus, die diese fragmente enthaltende impfstoffzusammensetzung und die diagnostischen kits
DE60124523D1 (de) Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
ATE443076T1 (de) Von protease typ ii spaltbares peptid
ATE403726T1 (de) Cytokin-proteinfamilie
DE69836758D1 (de) Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE330011T1 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
DE60118898D1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
MXPA05009954A (es) Familia de proteinas secretadas.
DK2186898T3 (da) Blomstrings-induktion
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
MXPA06013176A (es) Dominios semejantes al factor de crecimiento epidermico de mucina 3.
ATE525396T1 (de) Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn
ATE397753T1 (de) Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung
DE60027419D1 (de) Regulatorische Sequenzen des humanen MCP-1 Gens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties